{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T01:35:56Z","timestamp":1767922556719,"version":"3.49.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"32","license":[{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8,12]]},"abstract":"<jats:p>The differences between Chinese herbal medicine (CHM)- and Western medicine (WM)-induced liver injury have rarely been reported. Our aim was to investigate the clinical features of patients with drug-induced liver injury (DILI) caused by CHM or WM.<\/jats:p>\n          <jats:p>The medical records of 726 DILI patients were retrospectively collected at Peking University First Hospital from January 1995 through August 2019.<\/jats:p>\n          <jats:p>The number of inpatients with DILI in our hospital showed an increasing trend over time. The incidence of DILI caused by CHM exhibited a linear trend toward an increase with time (<jats:italic toggle=\"yes\">P<\/jats:italic> = .0012). Of the 726 DILI patients, females accounted for 65.8%. There were 353 cases (48.6%) caused by CHM and 225 cases (40.0%) caused by WM. The 3 most common causative CHMs were <jats:italic toggle=\"yes\">Polygonum multiflorum<\/jats:italic> (38 cases), Fructus Psoraleae (35 cases), and <jats:italic toggle=\"yes\">Epimedium<\/jats:italic> (26 cases). The proportions of female patients, alanine aminotransferase (ALT) levels, aspartate aminotransferase (AST) levels, total bilirubin (TBIL) levels and antinuclear antibody (ANA) positivity rates among cases caused by CHM were higher than those of cases caused by WM (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .05). There were more patients with severe cases caused by CHM than with severe cases caused by WM (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .05).<\/jats:p>\n          <jats:p>The clinical characteristics of DILI caused by CHM differ from those caused by WM. The incidence of DILI caused by CHM is increasing yearly. The medication time of DILI caused by CHM is longer than that of DILI caused by WM, and the severity is greater. Therefore, it is necessary to scientifically and rationally use traditional CHM and monitor liver function. For DILI caused by CHM, the CHM prescription should be recorded in detail to provide detailed clinical data for scientific research on the liver toxicity of CHM.<\/jats:p>","DOI":"10.1097\/md.0000000000029909","type":"journal-article","created":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T14:14:06Z","timestamp":1660313646000},"page":"e29909","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Differences in clinical characteristics among 726 patients with Chinese herbal medicine- or Western medicine-induced liver injury"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7060-8714","authenticated-orcid":false,"given":"Kangan","family":"Tan","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Peking University First Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanna","family":"Yang","sequence":"additional","affiliation":[{"name":"Center of Liver Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Amht Group Aerospace 731 Hospital, Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengqin","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Peking University First Hospital, Beijing, China"},{"name":"Department of Infectious Diseases, Peking University International Hospital, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"878","DOI":"10.14309\/ajg.0000000000001259","article-title":"Reddy KR: ACG clinical guideline: diagnosis and management of idiosyncratic drug-induced liver injury.","volume":"116","author":"Chalasani","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/hep.23937","article-title":"Drug-induced acute liver failure: results of a U.S. multicenter, prospective study.","volume":"52","author":"Reuben","year":"2010","journal-title":"Hepatology"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0140-6736(10)60274-7","article-title":"Acute liver failure.","volume":"376","author":"Bernal","year":"2010","journal-title":"Lancet"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/ajg.2012.138","article-title":"A prospective nationwide study of drug-induced liver injury in Korea.","volume":"107","author":"Suk","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1053\/j.gastro.2019.02.002","article-title":"Incidence and etiology of drug-induced liver injury in mainland China.","volume":"156","author":"Shen","year":"2019","journal-title":"Gastroenterology"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/hepr.13288","article-title":"Analysis of 307 cases with drug-induced liver injury between 2010 and 2018 in Japan.","volume":"49","author":"Aiso","year":"2019","journal-title":"Hepatol Res"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/MEG.0b013e32835f6889","article-title":"Epidemiology of drug-induced liver injury in China: a systematic analysis of the Chinese literature including 21,789 patients.","volume":"25","author":"Zhou","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1478-3231.2007.01461.x","article-title":"Drug-induced liver injury at an Asian center: a prospective study.","volume":"27","author":"Wai","year":"2007","journal-title":"Liver Int"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12664-018-0820-6","article-title":"Ayurvedic and herbal medicine-induced liver injury: it is time to wake up and take notice.","volume":"37","author":"Devarbhavi","year":"2018","journal-title":"Indian J Gastroenterol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/hep.27317","article-title":"Liver injury from herbals and dietary supplements in the U.S. drug-induced liver injury network.","volume":"60","author":"Navarro","year":"2014","journal-title":"Hepatology"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.3748\/wjg.v25.i46.6704","article-title":"Severe liver injury due to herbal and dietary supplements and the role of liver transplantation.","volume":"25","author":"Grewal","year":"2019","journal-title":"World J Gastroenterol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0168-8278(90)90124-A","article-title":"Criteria of drug-induced liver disorders. Report of an international consensus meeting.","volume":"11","author":"Benichou","year":"1990","journal-title":"J Hepatol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"13205","DOI":"10.1021\/acs.jmedchem.0c00626","article-title":"Chinese therapeutic strategy for fighting COVID-19 and potential small-molecule inhibitors against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).","volume":"63","author":"Choudhry","year":"2020","journal-title":"J Med Chem"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/j.gastro.2008.09.011","article-title":"Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.","volume":"135","author":"Chalasani","year":"2008","journal-title":"Gastroenterology"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1007\/s00204-020-02885-1","article-title":"Drug induced liver injury: an update.","volume":"94","author":"Garcia-Cortes","year":"2020","journal-title":"Arch Toxicol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1007\/s10620-019-06030-6","article-title":"Characteristics of drug-induced liver injury in Northeast China: disease spectrum and drug types.","volume":"65","author":"Zhang","year":"2020","journal-title":"Dig Dis Sci"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.maturitas.2009.05.006","article-title":"Suspected black cohosh hepatotoxicity\u2014challenges and pitfalls of causality assessment.","volume":"63","author":"Teschke","year":"2009","journal-title":"Maturitas"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/gme.0b013e3181c5159c","article-title":"Black cohosh and suspected hepatotoxicity: inconsistencies, confounding variables, and prospective use of a diagnostic causality algorithm. A critical review.","volume":"17","author":"Teschke","year":"2010","journal-title":"Menopause"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yrtph.2012.02.009","article-title":"Spontaneous reports of primarily suspected herbal hepatotoxicity by Pelargonium sidoides: was causality adequately ascertained?","volume":"63","author":"Teschke","year":"2012","journal-title":"Regul Toxicol Pharmacol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1665-2681(19)31380-8","article-title":"Herbal hepatotoxicity and WHO global introspection method.","volume":"12","author":"Teschke","year":"2013","journal-title":"Ann Hepatol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.3748\/wjg.v26.i12.1329","article-title":"Single-nucleotide polymorphisms of HLA and Polygonum multiflorum-induced liver injury in the Han Chinese population.","volume":"26","author":"Yang","year":"2020","journal-title":"World J Gastroenterol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastro.2005.05.006","article-title":"Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period.","volume":"129","author":"Andrade","year":"2005","journal-title":"Gastroenterology"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/hep.27317","article-title":"Liver injury from herbals and dietary supplements in the U.S. Drug-induced liver injury network.","volume":"60","author":"Navarro","year":"2014","journal-title":"Hepatology"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.cgh.2017.12.051","article-title":"Herbal and dietary supplement-induced liver injuries in the Spanish DILI registry.","volume":"16","author":"Medina-Caliz","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R25-20250504","first-page":"47","article-title":"Predictors of poor outcomes in 488 patients with herb-induced liver injury.","volume":"30","author":"Zhu","year":"2019","journal-title":"Turk J Gastroenterol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1111\/jgh.13323","article-title":"Hepatobiliary and pancreatic: comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients.","volume":"31","author":"Zhu","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2014.03.045","article-title":"Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset.","volume":"147","author":"Fontana","year":"2014","journal-title":"Gastroenterology"},{"key":"R28-20250504","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094557","article-title":"Immune-mediated drug-induced liver injury: immunogenetics and experimental models.","volume":"22","author":"Gerussi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R29-20250504","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18091954","article-title":"\u201cAutoimmune(-Like)\u201d drug and herb induced liver injury: new insights into molecular pathogenesis.","volume":"18","author":"Sebode","year":"2017","journal-title":"Int J Mol Sci"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s12328-016-0648-5","article-title":"Autoimmune hepatitis following drug-induced liver injury in an elderly patient.","volume":"9","author":"Kumagai","year":"2016","journal-title":"Clin J Gastroenterol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jhep.2010.12.041","article-title":"Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis.","volume":"55","author":"Lucena","year":"2011","journal-title":"J Hepatol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1111\/liv.12958","article-title":"Chronic liver injury induced by drugs: a systematic review.","volume":"35","author":"Stine","year":"2015","journal-title":"Liver Int"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1055\/s-0034-1375954","article-title":"Genetic basis of drug-induced liver injury: present and future.","volume":"34","author":"Urban","year":"2014","journal-title":"Semin Liver Dis"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/hep.30660","article-title":"HLA-B*35:01 Allele is a potential biomarker for predicting polygonum multiflorum-induced liver injury in humans.","volume":"70","author":"Li","year":"2019","journal-title":"Hepatology"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41398-020-01129-1","article-title":"Meta-analysis of probability estimates of worldwide variation of CYP2D6 and CYP2C19.","volume":"11","author":"Koopmans","year":"2021","journal-title":"Transl Psychiatry"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jamadermatol.2013.4114","article-title":"Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis.","volume":"149","author":"Tangamornsuksan","year":"2013","journal-title":"JAMA Dermatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029909","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:00:26Z","timestamp":1746334826000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,12]]},"references-count":36,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000029909","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,12]]}}}